The U.S. Food and Drug Administration has decided there is no need for a second study to determine that the migraine drug Levadex is effective. Drugmaker MAP Pharmaceuticals says the orally inhaled migraine med reached all four of its goals in a late-stage study, and the company is now moving forward on remaining clinical trails with a goal of getting the drug approved in late 2010.
Many of you receive our weekly newsletter on Tuesday and have told me how much you like it. For anyone who's not subscribed, just go to the... Read more »
I'd like to share a recent experience I've had with my doctor's office and my head. I'd been suffering a bad Migraine cycle since my last... Read more »
Full Question: Hi! I saw an MS specialist at the Cleveland Clinic on Monday and the guy blew me off. I am very frustrated. I am... Read more »
I saw my new specialist for my second appointment. on March 29, 2010. Unfortunately, I didn't take detailed notes at this... Read more »
This past week was a real trial for me. On Thursday when my Migraine attack hit, I felt confident that Axert would take care of it. After... Read more »
The first time I remember having a Migraine attack was when I was six-years-old. At the time, I didn’t realize what it was. There were these... Read more »
Tuesdays New York Times article Scientists Cast Misery of Migraine in a New Light highlights research that indicates that much of what we think... Read more »